|
G |
A2m |
alpha-2-macroglobulin |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of A2M protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Abcb6 |
ATP binding cassette subfamily B member 6 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ABCB6 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ABCG5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
multiple interactions decreases phosphorylation |
ISO |
cyhalothrin promotes the reaction [Oleic Acid results in increased expression of ACACA protein] cyhalothrin results in decreased phosphorylation of ACACA protein |
CTD |
PMID:36529352 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACKR3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
|
|
G |
Acsbg2 |
acyl-CoA synthetase bubblegum family member 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACSBG2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:1,683,846...1,715,517
Ensembl chr 9:1,683,847...1,714,518
|
|
G |
Actn1 |
actinin, alpha 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACTN1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Adamts7 |
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ADAMTS7 protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:90,704,727...90,744,333
Ensembl chr 8:90,704,727...90,744,328
|
|
G |
Adcy2 |
adenylate cyclase 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADCY2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:34,375,639...34,822,252
Ensembl chr 1:34,375,895...34,822,236
|
|
G |
Add1 |
adducin 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADD1 protein |
CTD |
PMID:34896426 |
|
NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
increases expression |
EXP |
cyhalothrin results in increased expression of ADH4 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adh6 |
alcohol dehydrogenase 6 (class V) |
increases expression |
EXP |
cyhalothrin results in increased expression of ADH6 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 2:226,903,208...226,934,564
Ensembl chr 2:226,903,250...226,934,534
|
|
G |
Aebp1 |
AE binding protein 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AEBP1 protein |
CTD |
PMID:34896426 |
|
NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
increases expression |
EXP |
cyhalothrin results in increased expression of AIF1 protein |
CTD |
PMID:37060950 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases activity |
ISO |
cyhalothrin results in increased activity of AKT1 |
CTD |
PMID:26969072 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
cyhalothrin results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of ALDH1B1 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
|
|
G |
Aldh3b1 |
aldehyde dehydrogenase 3 family, member B1 |
increases expression |
EXP |
cyhalothrin results in increased expression of ALDH3B1 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 1:201,145,309...201,162,675
Ensembl chr 1:201,145,309...201,163,921
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ALOX15 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Amh |
anti-Mullerian hormone |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of AMH mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of AMH mRNA |
CTD |
PMID:34896426 PMID:36053783 |
|
NCBI chr 7:8,906,776...8,909,192
Ensembl chr 7:8,906,836...8,909,282
|
|
G |
Ankh |
ANKH inorganic pyrophosphate transport regulator |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANKH protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:78,153,027...78,280,181
Ensembl chr 2:78,153,026...78,280,187
|
|
G |
Anxa6 |
annexin A6 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANXA6 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
|
|
G |
Ar |
androgen receptor |
decreases activity multiple interactions |
ISO EXP |
cyhalothrin results in decreased activity of AR protein [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of AR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of AR mRNA cyhalothrin inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA] |
CTD |
PMID:20410157 PMID:21310686 PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Armc5 |
armadillo repeat containing 5 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ARMC5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:182,820,141...182,826,913
Ensembl chr 1:182,820,141...182,826,907
|
|
G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of ARPC1B protein |
CTD |
PMID:34896426 |
|
NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747
|
|
G |
Atn1 |
atrophin 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ATN1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:157,554,287...157,568,092
Ensembl chr 4:157,551,276...157,568,132
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ATP2A1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
|
|
G |
Avil |
advillin |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AVIL protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP |
cyhalothrin results in increased expression of BAX mRNA; cyhalothrin results in increased expression of BAX protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BAX mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BAX mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of BAX mRNA |
CTD |
PMID:29727961 PMID:30029170 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcan |
brevican |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BCAN protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:173,454,479...173,467,717
Ensembl chr 2:173,454,482...173,467,460
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
EXP |
cyhalothrin results in decreased expression of BCL2 protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BCL2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of BCL2 mRNA |
CTD |
PMID:30029170 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRCA1 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brdt |
bromodomain testis associated |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRDT protein |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr14:2,387,372...2,445,857
Ensembl chr14:2,387,796...2,445,842
|
|
G |
Brinp3 |
BMP/retinoic acid inducible neural specific 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRINP3 protein |
CTD |
PMID:34896426 |
|
NCBI chr13:58,413,883...58,846,828
Ensembl chr13:58,413,883...58,846,770
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1C protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
|
|
G |
Cacna1s |
calcium voltage-gated channel subunit alpha1 S |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1S protein |
CTD |
PMID:34896426 |
|
NCBI chr13:47,493,949...47,564,194
Ensembl chr13:47,493,949...47,564,318
|
|
G |
Cacna2d1 |
calcium voltage-gated channel auxiliary subunit alpha2delta 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA2D1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
decreases expression multiple interactions |
EXP |
cyhalothrin results in decreased expression of CAMK2A protein cyhalothrin promotes the reaction [NGF protein results in increased expression of CAMK2A mRNA] |
CTD |
PMID:28385489 PMID:28487251 |
|
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
multiple interactions |
EXP |
cyhalothrin promotes the reaction [NGF protein results in increased expression of CAMK2B mRNA] |
CTD |
PMID:28385489 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Camkk1 |
calcium/calmodulin-dependent protein kinase kinase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CAMKK1 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:57,637,335...57,660,498
Ensembl chr10:57,637,391...57,660,498
|
|
G |
Camsap1 |
calmodulin regulated spectrin-associated protein 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CAMSAP1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:8,746,176...8,806,067
Ensembl chr 3:8,746,176...8,806,072
|
|
G |
Carmil3 |
capping protein regulator and myosin 1 linker 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CARMIL3 protein |
CTD |
PMID:34896426 |
|
NCBI chr15:28,978,440...28,995,865
Ensembl chr15:28,979,007...28,996,225
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
EXP |
cyhalothrin results in increased expression of CASP3 mRNA [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP3 mRNA |
CTD |
PMID:29727961 PMID:34896426 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CASP9 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CASP9 mRNA |
CTD |
PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions increases activity decreases activity |
EXP ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the activity of CAT protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased activity of CAT protein; thymoquinone inhibits the reaction [cyhalothrin results in decreased activity of CAT protein] cyhalothrin results in increased activity of CAT protein |
CTD |
PMID:26645134 PMID:27348886 PMID:28058584 PMID:33396045 PMID:35678313 PMID:36529352 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cc2d1a |
coiled-coil and C2 domain containing 1A |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CC2D1A protein |
CTD |
PMID:34896426 |
|
NCBI chr19:24,011,897...24,026,937
Ensembl chr19:24,011,938...24,026,936
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
EXP |
cyhalothrin results in increased expression of CCL2 protein |
CTD |
PMID:27348886 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccn1 |
cellular communication network factor 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CCN1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccnd1 |
cyclin D1 |
affects expression multiple interactions |
ISO |
cyhalothrin affects the expression of CCND1 mRNA fulvestrant inhibits the reaction [cyhalothrin affects the expression of CCND1 mRNA] |
CTD |
PMID:26877835 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd9 |
CD9 molecule |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CD9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CD9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CD9 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cdh22 |
cadherin 22 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CDH22 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:153,845,563...153,970,630
Ensembl chr 3:153,845,787...153,970,588
|
|
G |
Cdk5 |
cyclin-dependent kinase 5 |
increases expression |
EXP |
cyhalothrin results in increased expression of CDK5 protein |
CTD |
PMID:28487251 |
|
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
|
|
G |
Cdk5rap2 |
CDK5 regulatory subunit associated protein 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CDK5RAP2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:83,792,282...83,961,129
Ensembl chr 5:83,792,284...83,960,782
|
|
G |
Ces1d |
carboxylesterase 1D |
multiple interactions increases metabolic processing |
ISO |
CES1 protein inhibits the reaction [cyhalothrin results in increased activity of NR1I2 protein] CES1 protein results in increased metabolism of cyhalothrin |
CTD |
PMID:19249324 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Ces2e |
carboxylesterase 2E |
affects metabolic processing |
ISO |
CES2E protein affects the metabolism of cyhalothrin |
CTD |
PMID:15123619 |
|
NCBI chr19:157,447...172,822
Ensembl chr19:157,407...172,856
|
|
G |
Cftr |
CF transmembrane conductance regulator |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CFTR protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Ciita |
class II, major histocompatibility complex, transactivator |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CIITA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CIITA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CIITA mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of CIITA mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
|
|
G |
Clu |
clusterin |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CLU mRNA |
CTD |
PMID:33051911 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cntn3 |
contactin 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CNTN3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:134,841,268...135,214,460
Ensembl chr 4:134,842,266...135,125,613
|
|
G |
Col27a1 |
collagen type XXVII alpha 1 chain |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COL27A1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:76,647,302...76,765,989
Ensembl chr 5:76,647,429...76,765,174
|
|
G |
Colec12 |
collectin sub-family member 12 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COLEC12 protein |
CTD |
PMID:34896426 |
|
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
|
|
G |
Cops2 |
COP9 signalosome subunit 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COPS2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:113,084,174...113,110,090
Ensembl chr 3:113,084,176...113,109,947
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
decreases phosphorylation multiple interactions decreases expression |
EXP |
cyhalothrin results in decreased phosphorylation of CREB1 protein [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CREB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CREB1 mRNA cyhalothrin results in decreased expression of CREB1 protein modified form |
CTD |
PMID:28487251 PMID:28495607 PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crebbp |
CREB binding protein |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CREBBP mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREBBP mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Crem |
cAMP responsive element modulator |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CREM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREM mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of CREM mRNA |
CTD |
PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYBB mRNA |
CTD |
PMID:33396045 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases expression multiple interactions |
EXP |
cyhalothrin results in decreased expression of CYP11A1 protein [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of CYP11A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CYP11A1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CYP11A1 mRNA |
CTD |
PMID:30029170 PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP17A1 protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CYP17A1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP19A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP19A1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression increases activity |
EXP |
cyhalothrin results in increased expression of CYP1A1 mRNA cyhalothrin results in increased activity of CYP1A1 protein |
CTD |
PMID:29727961 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity increases expression |
ISO EXP |
cyhalothrin results in increased activity of CYP1A2 protein cyhalothrin results in increased expression of CYP1A2 mRNA |
CTD |
PMID:22310298 PMID:29727961 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of CYP26B1 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
increases activity increases expression |
EXP |
cyhalothrin results in increased activity of CYP2A1 protein cyhalothrin results in increased expression of CYP2A1 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases activity increases expression |
EXP |
cyhalothrin results in increased activity of CYP2B1 protein cyhalothrin results in increased expression of CYP2B1 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
cyhalothrin results in increased expression of CYP2B2 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases activity decreases activity multiple interactions increases expression |
ISO |
cyhalothrin results in increased activity of CYP2B6 protein cyhalothrin results in decreased activity of CYP2B6 protein cyhalothrin inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] cyhalothrin results in increased expression of CYP2B6 mRNA |
CTD |
PMID:22310298 PMID:22634058 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c22 |
cytochrome P450, family 2, subfamily c, polypeptide 22 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of CYP2C22 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 1:238,991,698...239,031,323
Ensembl chr 1:238,991,610...239,021,738
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases activity increases expression |
ISO EXP |
cyhalothrin results in decreased activity of CYP2D6 protein cyhalothrin results in increased expression of CYP2D4 mRNA |
CTD |
PMID:20183062 PMID:29727961 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases expression |
EXP |
cyhalothrin results in increased expression of CYP2E1 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2t1 |
cytochrome P450, family 2, subfamily t, polypeptide 1 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of CYP2T1 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 1:82,446,321...82,451,564
Ensembl chr 1:82,446,921...82,451,563
|
|
G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
increases expression |
EXP |
cyhalothrin results in increased expression of CYP3A18 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr12:8,880,509...8,930,382
Ensembl chr12:8,880,528...8,930,381
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression decreases activity multiple interactions increases activity |
EXP ISO |
cyhalothrin results in increased expression of CYP3A2 mRNA cyhalothrin results in decreased activity of CYP3A4 protein [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in increased expression of CYP3A4 mRNA cyhalothrin results in increased activity of CYP3A4 protein cyhalothrin results in increased expression of CYP3A4 mRNA; cyhalothrin results in increased expression of CYP3A4 protein |
CTD |
PMID:19249324 PMID:20183062 PMID:22310298 PMID:25028461 PMID:29727961 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression |
EXP |
cyhalothrin results in increased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
increases expression |
EXP |
cyhalothrin results in increased expression of CYP4A1 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4f4 |
cytochrome P450, family 4, subfamily f, polypeptide 4 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP4F4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:11,717,208...11,733,507
Ensembl chr 7:11,717,208...11,733,506
|
|
G |
Dazap1 |
DAZ associated protein 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 7:9,423,673...9,448,116
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDR1 protein |
CTD |
PMID:34896426 |
|
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Ddx25 |
DEAD-box helicase 25 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX25 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DDX25 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX25 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 8:33,894,224...33,910,377
Ensembl chr 8:33,894,232...33,921,764
|
|
G |
Ddx3y |
DEAD box helicase 3, Y-linked |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX3Y mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX3Y mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr Y:1,115,095...1,135,754
Ensembl chr Y:1,116,309...1,135,706
|
|
G |
Ddx46 |
DEAD-box helicase 46 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX46 protein |
CTD |
PMID:34896426 |
|
NCBI chr17:8,942,070...8,988,440
Ensembl chr17:8,944,454...8,988,439
|
|
G |
Dhx30 |
DExH-box helicase 30 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DHX30 protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:110,064,751...110,096,954
Ensembl chr 8:110,064,752...110,097,381
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DLG2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
multiple interactions decreases expression increases expression |
ISO EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cyhalothrin results in increased expression of DLG4]; cyhalothrin inhibits the reaction [Estradiol results in increased expression of DLG4 protein]; fulvestrant inhibits the reaction [cyhalothrin results in increased expression of DLG4 protein] cyhalothrin results in decreased expression of DLG4 protein |
CTD |
PMID:26969072 PMID:28487251 |
|
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
|
|
G |
Dlst |
dihydrolipoamide S-succinyltransferase |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DLST protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT1 mRNA |
CTD |
PMID:33051911 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3A mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of DNMT3A mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3B mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT3B mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Drd1 |
dopamine receptor D1 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of DRD1 mRNA |
CTD |
PMID:36126889 |
|
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
|
|
G |
Drd2 |
dopamine receptor D2 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of DRD2 mRNA; cyhalothrin results in decreased expression of DRD2 protein |
CTD |
PMID:22366556 PMID:28495607 PMID:36126889 |
|
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Duox2 |
dual oxidase 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DUOX2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
|
|
G |
Ecel1 |
endothelin converting enzyme-like 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ECEL1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:87,819,516...87,829,154
Ensembl chr 9:87,816,718...87,826,675
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases activity |
ISO |
cyhalothrin results in increased activity of EIF4EBP1 |
CTD |
PMID:26969072 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Elac2 |
elaC ribonuclease Z 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ELAC2 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:49,632,308...49,655,614
Ensembl chr10:49,632,378...49,655,614
|
|
G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
increases expression |
EXP |
cyhalothrin results in increased expression of ENTPD1 mRNA |
CTD |
PMID:31421116 |
|
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
|
|
G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
increases expression |
EXP |
cyhalothrin results in increased expression of ENTPD2 mRNA |
CTD |
PMID:31421116 |
|
NCBI chr 3:8,213,575...8,219,094
Ensembl chr 3:8,213,663...8,226,866
|
|
G |
Entpd3 |
ectonucleoside triphosphate diphosphohydrolase 3 |
increases expression |
EXP |
cyhalothrin results in increased expression of ENTPD3 mRNA |
CTD |
PMID:31421116 |
|
NCBI chr 8:120,246,412...120,277,943
Ensembl chr 8:120,247,121...120,277,943
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of EP300 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EP300 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of EP300 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epha3 |
Eph receptor A3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA3 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:1,138,485...1,474,102
Ensembl chr11:1,140,985...1,473,900
|
|
G |
Epha6 |
Eph receptor A6 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA6 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:39,757,501...40,708,901
Ensembl chr11:39,757,181...40,698,311
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
affects binding |
ISO |
cyhalothrin binds to ERBB2 protein |
CTD |
PMID:32278787 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ERBB3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erc2 |
ELKS/RAB6-interacting/CAST family member 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ERC2 protein |
CTD |
PMID:34896426 |
|
NCBI chr16:2,812,712...3,673,624
Ensembl chr16:2,848,620...3,670,776
|
|
G |
Ercc3 |
ERCC excision repair 3, TFIIH core complex helicase subunit |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ERCC3 protein |
CTD |
PMID:34896426 |
|
NCBI chr18:23,883,613...23,914,326
Ensembl chr18:23,883,580...23,914,329
|
|
G |
Esm1 |
endothelial cell-specific molecule 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ESM1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804
|
|
G |
Esr1 |
estrogen receptor 1 |
increases activity increases expression multiple interactions decreases expression |
EXP ISO |
cyhalothrin results in increased activity of ESR1 protein cyhalothrin results in increased expression of ESR1 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cyhalothrin results in increased expression of ESR1]; fulvestrant inhibits the reaction [cyhalothrin results in increased expression of ESR1] cyhalothrin results in decreased expression of ESR1 mRNA; cyhalothrin results in decreased expression of ESR1 protein |
CTD |
PMID:18419197 PMID:20097460 PMID:20410157 PMID:26969072 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
decreases expression |
ISO |
cyhalothrin results in decreased expression of ESR2 mRNA; cyhalothrin results in decreased expression of ESR2 protein |
CTD |
PMID:18419197 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Exoc3 |
exocyst complex component 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EXOC3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:29,091,298...29,122,056
Ensembl chr 1:29,091,294...29,122,045
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EZH2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of EZH2 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
Farp1 |
FERM, ARH/RhoGEF and pleckstrin domain protein 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FARP1 protein |
CTD |
PMID:34896426 |
|
NCBI chr15:98,124,304...98,363,299
Ensembl chr15:98,182,329...98,363,299
|
|
G |
Fasn |
fatty acid synthase |
increases expression multiple interactions |
EXP ISO |
cyhalothrin results in increased expression of FASN mRNA; cyhalothrin results in increased expression of FASN protein [cyhalothrin co-treated with Oleic Acid] results in increased expression of FASN protein; Metformin inhibits the reaction [[cyhalothrin co-treated with Oleic Acid] results in increased expression of FASN protein] |
CTD |
PMID:27348886 PMID:36529352 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbln5 |
fibulin 5 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FBLN5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:120,899,219...120,977,829
Ensembl chr 6:120,899,224...120,977,755
|
|
G |
Fem1b |
fem-1 homolog B |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FEM1B protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:63,265,301...63,278,577
Ensembl chr 8:63,265,301...63,278,577
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
decreases expression |
ISO |
cyhalothrin results in decreased expression of FGF21 mRNA; cyhalothrin results in decreased expression of FGF21 protein |
CTD |
PMID:36529352 |
|
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
affects binding |
ISO |
cyhalothrin binds to FGFR2 protein |
CTD |
PMID:32278787 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fhl5 |
four and a half LIM domains 5 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FHL5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:38,907,941...38,956,759
Ensembl chr 5:38,907,946...38,956,552
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FLT1 protein |
CTD |
PMID:34896426 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Flt4 |
Fms related receptor tyrosine kinase 4 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FLT4 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:33,913,725...33,954,770
Ensembl chr10:33,913,608...33,954,770
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
increases expression |
EXP |
cyhalothrin results in increased expression of FMO5 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
decreases expression increases expression multiple interactions |
EXP |
cyhalothrin results in decreased expression of FSHB protein cyhalothrin results in increased expression of FSHB protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FSHB protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of FSHB protein; Taurine inhibits the reaction [cyhalothrin results in decreased expression of FSHB protein] |
CTD |
PMID:29506456 PMID:30029170 PMID:34896426 PMID:36053783 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fshr |
follicle stimulating hormone receptor |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of FSHR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FSHR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of FSHR mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
Gap43 |
growth associated protein 43 |
multiple interactions |
EXP |
cyhalothrin promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] |
CTD |
PMID:28385489 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GARS1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
|
|
G |
Gata4 |
GATA binding protein 4 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of GATA4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of GATA4 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of GATA4 mRNA |
CTD |
PMID:33051911 PMID:34896426 PMID:36053783 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
|
|
G |
Gc |
GC, vitamin D binding protein |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GC protein |
CTD |
PMID:34896426 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GCLC protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GDNF mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of GDNF mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of GDNF mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression |
EXP |
cyhalothrin results in increased expression of GFAP protein |
CTD |
PMID:37060950 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GFRA1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GFRA1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
|
|
G |
Gimap8 |
GTPase, IMAP family member 8 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GIMAP8 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:77,600,104...77,611,593
Ensembl chr 4:77,600,186...77,611,590
|
|
G |
Gnl1 |
G protein nucleolar 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GNL1 protein |
CTD |
PMID:34896426 |
|
NCBI chr20:2,783,130...2,792,115
Ensembl chr20:2,778,985...2,792,115
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of GNRH1 protein |
CTD |
PMID:34896426 |
|
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
|
|
G |
Gphn |
gephyrin |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GPHN protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:96,954,365...97,483,617
Ensembl chr 6:96,892,148...97,483,612
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases activity multiple interactions |
EXP ISO |
cyhalothrin results in increased activity of GPT protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the activity of GPT protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased activity of GPT protein |
CTD |
PMID:28058584 PMID:33396045 PMID:35678313 PMID:36529352 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gria3 |
glutamate ionotropic receptor AMPA type subunit 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIA3 protein |
CTD |
PMID:34896426 |
|
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
|
|
G |
Grik5 |
glutamate ionotropic receptor kainate type subunit 5 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIK5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of GRIN1 mRNA; cyhalothrin results in decreased expression of GRIN1 protein |
CTD |
PMID:28487251 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
decreases expression |
EXP |
cyhalothrin results in decreased expression of GRIN2B mRNA; cyhalothrin results in decreased expression of GRIN2B protein |
CTD |
PMID:28487251 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Grm1 |
glutamate metabotropic receptor 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRM1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:5,058,285...5,453,170
Ensembl chr 1:5,058,292...5,453,170
|
|
G |
Grm5 |
glutamate metabotropic receptor 5 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRM5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:141,310,069...141,884,980
Ensembl chr 1:141,312,368...141,882,274
|
|
G |
Grn |
granulin precursor |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRN protein |
CTD |
PMID:34896426 |
|
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases activity |
EXP |
cyhalothrin results in increased activity of GSR protein |
CTD |
PMID:29727961 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gtf2i |
general transcription factor II I |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GTF2I protein |
CTD |
PMID:34896426 |
|
NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243
|
|
G |
Gucy2d |
guanylate cyclase 2D, retinal |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GUCY2E protein |
CTD |
PMID:34896426 |
|
NCBI chr10:53,954,918...53,975,576
Ensembl chr10:53,959,010...53,974,067
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions |
ISO |
[fludioxonil co-treated with cyprodinil co-treated with procymidone co-treated with iprodione co-treated with cyhalothrin] results in increased phosphorylation of H2AX protein |
CTD |
PMID:22389207 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HADHA protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HDAC1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hdac10 |
histone deacetylase 10 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC10 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC10 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 7:120,199,126...120,205,850
Ensembl chr 7:120,199,129...120,204,228
|
|
G |
Hdac4 |
histone deacetylase 4 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HDAC4 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of HDAC4 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
|
|
G |
Hdc |
histidine decarboxylase |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HDC mRNA |
CTD |
PMID:34896426 |
|
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HIF1A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HIF1A mRNA |
CTD |
PMID:33396045 PMID:34896426 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hif3a |
hypoxia inducible factor 3 subunit alpha |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HIF3A protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMGCR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of HMGCR mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCS1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMGCS1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCS1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of HMGCS1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMOX1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMOX1 mRNA |
CTD |
PMID:33396045 PMID:34896426 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hp1bp3 |
heterochromatin protein 1, binding protein 3 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HP1BP3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HP1BP3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HP1BP3 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 5:150,435,781...150,463,004
Ensembl chr 5:150,433,740...150,463,000
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
increases expression |
EXP |
cyhalothrin results in increased expression of HPRT1 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of HSD11B1 mRNA; cyhalothrin results in decreased expression of HSD11B1 protein |
CTD |
PMID:30029170 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
decreases expression multiple interactions |
EXP |
cyhalothrin results in decreased expression of HSD17B3 mRNA [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSD17B3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSD17B3 mRNA; Taurine inhibits the reaction [cyhalothrin results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:29506456 PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression multiple interactions |
EXP |
cyhalothrin results in decreased expression of HSD3B1 mRNA; cyhalothrin results in decreased expression of HSD3B1 protein [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HSD3B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSD3B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HSD3B1 mRNA |
CTD |
PMID:30029170 PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsf2 |
heat shock transcription factor 2 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSF2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSF2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HSF2 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr20:36,819,864...36,847,490
Ensembl chr20:36,819,864...36,850,174
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
affects expression |
EXP |
cyhalothrin affects the expression of HTR1A mRNA |
CTD |
PMID:36126889 |
|
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
increases expression affects expression |
EXP |
cyhalothrin results in increased expression of HTR2A protein cyhalothrin affects the expression of HTR2A mRNA |
CTD |
PMID:22366556 PMID:36126889 |
|
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
|
|
G |
Htra4 |
HtrA serine peptidase 4 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HTRA4 protein |
CTD |
PMID:34896426 |
|
NCBI chr16:67,001,605...67,015,074
Ensembl chr16:67,001,605...67,015,074
|
|
G |
Ifng |
interferon gamma |
increases expression multiple interactions |
EXP |
cyhalothrin results in increased expression of IFNG mRNA; cyhalothrin results in increased expression of IFNG protein thymoquinone inhibits the reaction [cyhalothrin results in increased expression of IFNG mRNA]; thymoquinone inhibits the reaction [cyhalothrin results in increased expression of IFNG protein] |
CTD |
PMID:26645134 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igsf9 |
immunoglobulin superfamily, member 9 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein |
CTD |
PMID:34896426 |
|
NCBI chr13:84,948,643...84,965,616
Ensembl chr13:84,948,619...84,965,607
|
|
G |
Il10 |
interleukin 10 |
multiple interactions decreases expression |
EXP |
thymoquinone inhibits the reaction [cyhalothrin results in decreased expression of IL10 mRNA]; thymoquinone inhibits the reaction [cyhalothrin results in decreased expression of IL10 protein] cyhalothrin results in decreased expression of IL10 mRNA; cyhalothrin results in decreased expression of IL10 protein |
CTD |
PMID:26645134 PMID:37060950 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
EXP |
thymoquinone inhibits the reaction [cyhalothrin results in increased expression of IL1B mRNA]; thymoquinone inhibits the reaction [cyhalothrin results in increased expression of IL1B protein] cyhalothrin results in increased expression of IL1B mRNA; cyhalothrin results in increased expression of IL1B protein |
CTD |
PMID:26645134 PMID:28058584 PMID:37060950 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
multiple interactions decreases expression |
EXP |
thymoquinone inhibits the reaction [cyhalothrin results in decreased expression of IL4 mRNA]; thymoquinone inhibits the reaction [cyhalothrin results in decreased expression of IL4 protein] cyhalothrin results in decreased expression of IL4 mRNA; cyhalothrin results in decreased expression of IL4 protein |
CTD |
PMID:26645134 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
EXP |
thymoquinone inhibits the reaction [cyhalothrin results in increased expression of IL6 mRNA]; thymoquinone inhibits the reaction [cyhalothrin results in increased expression of IL6 protein] cyhalothrin results in increased expression of IL6 mRNA; cyhalothrin results in increased expression of IL6 protein |
CTD |
PMID:26645134 PMID:28058584 PMID:37060950 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Inhba |
inhibin subunit beta A |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of INHBA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of INHBA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of INHBA protein |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Insr |
insulin receptor |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of INSR protein |
CTD |
PMID:34896426 |
|
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Insrr |
insulin receptor-related receptor |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of INSRR protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:173,255,335...173,274,800
Ensembl chr 2:173,255,414...173,274,800
|
|
G |
Ints14 |
integrator complex subunit 14 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of INTS14 protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:65,475,788...65,500,807
Ensembl chr 8:65,475,910...65,500,804
|
|
G |
Iqsec3 |
IQ motif and Sec7 domain ArfGEF 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IQSEC3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:154,610,933...154,707,310
Ensembl chr 4:154,610,934...154,707,310
|
|
G |
Itpkc |
inositol-trisphosphate 3-kinase C |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ITPKC protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:82,500,957...82,522,533
Ensembl chr 1:82,500,957...82,522,779
|
|
G |
Itsn1 |
intersectin 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ITSN1 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:30,978,590...31,160,645
Ensembl chr11:30,978,590...31,160,645
|
|
G |
Jak1 |
Janus kinase 1 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of JAK1 protein |
CTD |
PMID:37060950 |
|
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Jak2 |
Janus kinase 2 |
increases expression |
EXP |
cyhalothrin results in increased expression of JAK2 protein |
CTD |
PMID:37060950 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Kbtbd8 |
kelch repeat and BTB domain containing 8 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KBTBD8 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:127,675,967...127,688,785
Ensembl chr 4:127,676,141...127,687,697
|
|
G |
Kcna5 |
potassium voltage-gated channel subfamily A member 5 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNA5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697
|
|
G |
Kcnb2 |
potassium voltage-gated channel subfamily B member 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNB2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:3,567,012...4,028,564
Ensembl chr 5:3,569,685...4,028,599
|
|
G |
Kcnh3 |
potassium voltage-gated channel subfamily H member 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNH3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:130,365,593...130,383,859
Ensembl chr 7:130,366,011...130,383,855
|
|
G |
Kcnt1 |
potassium sodium-activated channel subfamily T member 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNT1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:8,682,964...8,736,615
Ensembl chr 3:8,682,113...8,736,667
|
|
G |
Kdm3a |
lysine demethylase 3A |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KDM3A protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
|
|
G |
Kiss1 |
KiSS-1 metastasis-suppressor |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of KISS1 protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of KISS1 protein |
CTD |
PMID:34896426 PMID:36053783 |
|
NCBI chr13:44,775,106...44,780,707
Ensembl chr13:44,774,823...44,780,612
|
|
G |
Kitlg |
KIT ligand |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of KITLG mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of KITLG mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of KITLG mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Klf4 |
KLF transcription factor 4 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KLF4 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
L3mbtl2 |
L3MBTL histone methyl-lysine binding protein 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of L3MBTL2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:113,186,303...113,209,706
Ensembl chr 7:113,186,370...113,207,489
|
|
G |
Lct |
lactase |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LCT protein |
CTD |
PMID:34896426 |
|
NCBI chr13:39,781,929...39,824,456
Ensembl chr13:39,781,929...39,824,456
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LEF1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Lep |
leptin |
increases expression |
EXP |
cyhalothrin results in increased expression of LEP protein |
CTD |
PMID:27348886 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lepr |
leptin receptor |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LEPR protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions decreases expression |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LHB protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of LHB protein; Taurine inhibits the reaction [cyhalothrin results in decreased expression of LHB protein] |
CTD |
PMID:29506456 PMID:30029170 PMID:34896426 PMID:36053783 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of LHCGR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LHCGR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of LHCGR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of LHR mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Lpar3 |
lysophosphatidic acid receptor 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LPAR3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:235,125,234...235,193,916
Ensembl chr 2:235,149,065...235,193,357
|
|
G |
Lpp |
LIM domain containing preferred translocation partner in lipoma |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LPP protein |
CTD |
PMID:34896426 |
|
NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597
|
|
G |
Lrrc8c |
leucine rich repeat containing 8 VRAC subunit C |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LRRC8C protein |
CTD |
PMID:34896426 |
|
NCBI chr14:4,223,901...4,315,590
Ensembl chr14:4,227,832...4,315,249
|
|
G |
Ltbp2 |
latent transforming growth factor beta binding protein 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LTBP2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
|
|
G |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAGI2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:14,386,389...15,870,036
Ensembl chr 4:14,386,399...15,870,240
|
|
G |
Mamdc4 |
MAM domain containing 4 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of MAMDC4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:8,382,387...8,391,003
Ensembl chr 3:8,382,387...8,391,003
|
|
G |
Man1b1 |
mannosidase, alpha, class 1B, member 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAN1B1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:8,143,877...8,165,007
Ensembl chr 3:8,143,381...8,165,006
|
|
G |
Man2c1 |
mannosidase, alpha, class 2C, member 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAN2C1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:57,537,879...57,549,691
Ensembl chr 8:57,537,321...57,549,690
|
|
G |
Maoa |
monoamine oxidase A |
increases expression |
EXP |
cyhalothrin results in increased expression of MAOA mRNA |
CTD |
PMID:36126889 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Maob |
monoamine oxidase B |
increases expression |
EXP |
cyhalothrin results in increased expression of MAOB mRNA |
CTD |
PMID:36126889 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAP3K1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of MAPK1 protein modified form |
CTD |
PMID:28487251 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of MAPK3 protein modified form |
CTD |
PMID:28487251 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mark1 |
microtubule affinity regulating kinase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MARK1 protein |
CTD |
PMID:34896426 |
|
NCBI chr13:96,450,189...96,555,304
Ensembl chr13:96,451,487...96,555,173
|
|
G |
MAST1 |
microtubule associated serine/threonine kinase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAST1 protein |
CTD |
PMID:34896426 |
|
NCBI chr19:23,216,418...23,244,224
Ensembl chr19:23,207,991...23,244,235
|
|
G |
Mcm9 |
minichromosome maintenance 9 homologous recombination repair factor |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MCM9 protein |
CTD |
PMID:34896426 |
|
NCBI chr20:32,818,219...32,929,577
Ensembl chr20:32,844,951...32,929,600
|
|
G |
Mcmdc2 |
minichromosome maintenance domain containing 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MCMDC2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:9,291,967...9,337,526
Ensembl chr 5:9,298,101...9,338,300
|
|
G |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of MDGA2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:84,746,422...85,608,640
Ensembl chr 6:84,761,941...85,608,126
|
|
G |
Med23 |
mediator complex subunit 23 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MED23 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:20,490,315...20,558,461
Ensembl chr 1:20,490,315...20,537,463
|
|
G |
Mlec |
malectin |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MLEC protein |
CTD |
PMID:34896426 |
|
NCBI chr12:41,458,234...41,468,710
Ensembl chr12:41,458,231...41,468,708
|
|
G |
Mmel1 |
membrane metallo-endopeptidase-like 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MMEL1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:165,431,278...165,461,716
Ensembl chr 5:165,431,343...165,461,716
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
affects binding |
ISO |
cyhalothrin binds to MMP9 protein |
CTD |
PMID:32278787 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mrc2 |
mannose receptor, C type 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MRC2 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:90,261,986...90,323,187
Ensembl chr10:90,261,394...90,322,856
|
|
G |
Mylip |
myosin regulatory light chain interacting protein |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein |
CTD |
PMID:34896426 |
|
NCBI chr17:19,286,649...19,308,295
Ensembl chr17:19,286,650...19,308,295
|
|
G |
Myo1a |
myosin IA |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYO1A protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:63,542,988...63,557,944
Ensembl chr 7:63,542,988...63,557,944
|
|
G |
Nbr1 |
NBR1, autophagy cargo receptor |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of NBR1 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:86,477,775...86,506,418
Ensembl chr10:86,478,290...86,506,412
|
|
G |
Ncoa7 |
nuclear receptor coactivator 7 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of NCOA7 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NCOA7 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of NCOA7 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 1:26,856,228...27,016,950
Ensembl chr 1:26,856,530...27,015,871
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NFE2L2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NFE2L2 mRNA |
CTD |
PMID:33396045 PMID:34896426 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases phosphorylation |
EXP |
cyhalothrin results in increased phosphorylation of NFKBIA protein |
CTD |
PMID:37060950 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
EXP |
cyhalothrin promotes the reaction [NGF protein results in decreased expression of TUBA3A mRNA]; cyhalothrin promotes the reaction [NGF protein results in increased expression of CAMK2A mRNA]; cyhalothrin promotes the reaction [NGF protein results in increased expression of CAMK2B mRNA]; cyhalothrin promotes the reaction [NGF protein results in increased expression of GAP43 mRNA]; cyhalothrin promotes the reaction [NGF protein results in increased expression of TUBB3 mRNA] |
CTD |
PMID:28385489 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nlk |
nemo like kinase |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NLK protein |
CTD |
PMID:34896426 |
|
NCBI chr10:63,467,388...63,590,960
Ensembl chr10:63,438,222...63,589,730
|
|
G |
Noc4l |
nucleolar complex associated 4 homolog |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NOC4L protein |
CTD |
PMID:34896426 |
|
NCBI chr12:46,016,077...46,020,615
Ensembl chr12:46,016,069...46,020,614
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression |
EXP |
cyhalothrin results in increased expression of NOS2 mRNA |
CTD |
PMID:37060950 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Npl |
N-acetylneuraminate pyruvate lyase |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NPL protein |
CTD |
PMID:34896426 |
|
NCBI chr13:65,655,099...65,697,464
Ensembl chr13:65,655,118...65,697,372
|
|
G |
Npr2 |
natriuretic peptide receptor 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NPR2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:57,883,171...57,901,590
Ensembl chr 5:57,883,171...57,901,580
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NQO1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NQO1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of NQO1 mRNA |
CTD |
PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of NR0B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NR0B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of NR0B1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr X:50,756,886...50,761,014
Ensembl chr X:50,756,886...50,761,011
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
cyhalothrin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity multiple interactions |
ISO EXP |
cyhalothrin results in increased activity of NR1I2 protein; cyhalothrin results in increased activity of NR1I2 protein polymorphism [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in increased activity of NR1I2 protein; CES1 protein inhibits the reaction [cyhalothrin results in increased activity of NR1I2 protein]; cyhalothrin binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:19249324 PMID:21115097 PMID:25028461 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
ISO |
cyhalothrin inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein] |
CTD |
PMID:26647222 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NR3C2 protein |
CTD |
PMID:34896426 |
|
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NR5A1 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328
|
|
G |
Nrxn2 |
neurexin 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NRXN2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:203,726,420...203,842,301
Ensembl chr 1:203,735,753...203,842,297
|
|
G |
Oas3 |
2'-5'-oligoadenylate synthetase 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of OAS3 protein |
CTD |
PMID:34896426 |
|
NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781
|
|
G |
Odf2 |
outer dense fiber of sperm tails 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ODF2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:13,160,981...13,207,223
Ensembl chr 3:13,161,494...13,206,985
|
|
G |
Or6a2 |
olfactory receptor family 6 subfamily A member 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of OR6A2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:160,827,258...160,828,241
Ensembl chr 1:160,793,997...160,831,557
|
|
G |
Orc4 |
origin recognition complex, subunit 4 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ORC4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:33,290,844...33,334,022
Ensembl chr 3:33,294,355...33,333,824
|
|
G |
Ovol1 |
ovo like transcriptional repressor 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of OVOL1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of OVOL1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of OVOL1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 1:202,855,261...202,868,858
Ensembl chr 1:202,855,265...202,866,831
|
|
G |
Pacs1 |
phosphofurin acidic cluster sorting protein 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PACS1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:202,437,503...202,569,473
Ensembl chr 1:202,437,505...202,569,473
|
|
G |
Paf1 |
PAF1 homolog, Paf1/RNA polymerase II complex component |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PAF1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:83,683,654...83,689,233
Ensembl chr 1:83,668,813...83,689,237
|
|
G |
Palm |
paralemmin |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PALM protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:9,886,634...9,912,389
Ensembl chr 7:9,886,643...9,912,555
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of PCNA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PCNA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of PCNA mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of PCNA mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pde4b |
phosphodiesterase 4B |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PDE4B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDE4B mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
|
|
G |
Pds5a |
PDS5 cohesin associated factor A |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDS5A protein |
CTD |
PMID:34896426 |
|
NCBI chr14:42,551,653...42,651,074
Ensembl chr14:42,552,647...42,648,669
|
|
G |
Pelp1 |
proline, glutamate and leucine rich protein 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PELP1 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:55,094,798...55,111,833
Ensembl chr10:55,094,796...55,111,994
|
|
G |
Pex6 |
peroxisomal biogenesis factor 6 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PEX6 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:14,258,145...14,270,335
Ensembl chr 9:14,258,145...14,270,303
|
|
G |
Pgap1 |
post-GPI attachment to proteins inositol deacylase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PGAP1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:55,975,574...56,044,325
Ensembl chr 9:55,975,667...56,044,464
|
|
G |
Pgr |
progesterone receptor |
increases expression affects binding |
ISO |
cyhalothrin results in increased expression of PGR mRNA cyhalothrin binds to PGR protein |
CTD |
PMID:18419197 PMID:32278787 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Phactr1 |
phosphatase and actin regulator 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PHACTR1 protein |
CTD |
PMID:34896426 |
|
NCBI chr17:21,560,364...22,040,166
Ensembl chr17:21,562,721...22,039,831
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIK3CA protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIK3CB protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
affects binding |
ISO |
cyhalothrin binds to PIK3CG protein |
CTD |
PMID:32278787 |
|
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
|
|
G |
Pip5k1a |
phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIP5K1A protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:182,628,299...182,671,584
Ensembl chr 2:182,628,300...182,671,598
|
|
G |
Plcb2 |
phospholipase C, beta 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLCB2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:105,683,676...105,704,384
Ensembl chr 3:105,684,815...105,704,302
|
|
G |
Pld1 |
phospholipase D1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLD1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692
|
|
G |
Plk3 |
polo-like kinase 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLK3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
|
|
G |
Plod3 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLOD3 protein |
CTD |
PMID:34896426 |
|
NCBI chr12:19,676,384...19,686,945
Ensembl chr12:19,676,386...19,686,960
|
|
G |
Pnlip |
pancreatic lipase |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PNLIP protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:257,774,012...257,811,656
Ensembl chr 1:257,798,581...257,811,654
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
increases expression decreases expression |
EXP ISO |
cyhalothrin results in increased expression of PPARA mRNA cyhalothrin results in decreased expression of PPARA mRNA; cyhalothrin results in decreased expression of PPARA protein |
CTD |
PMID:27348886 PMID:36529352 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression decreases expression affects expression multiple interactions |
EXP ISO |
cyhalothrin results in increased expression of PPARG mRNA cyhalothrin results in decreased expression of PPARG mRNA cyhalothrin affects the expression of PPARG protein [cyhalothrin co-treated with Oleic Acid] results in increased expression of PPARG protein; Metformin inhibits the reaction [[cyhalothrin co-treated with Oleic Acid] results in increased expression of PPARG protein] |
CTD |
PMID:27348886 PMID:36529352 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppfia4 |
PTPRF interacting protein alpha 4 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PPFIA4 protein |
CTD |
PMID:34896426 |
|
NCBI chr13:45,753,827...45,802,305
Ensembl chr13:45,753,827...45,802,261
|
|
G |
Ppig |
peptidylprolyl isomerase G |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PPIG protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:54,484,023...54,512,929
Ensembl chr 3:54,484,023...54,512,926
|
|
G |
Ppp1ca |
protein phosphatase 1 catalytic subunit alpha |
increases expression |
EXP |
cyhalothrin results in increased expression of PPP1CA protein |
CTD |
PMID:28495607 |
|
NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
|
|
G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
decreases expression |
EXP |
cyhalothrin results in decreased expression of PPP1R1B protein |
CTD |
PMID:28495607 |
|
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
|
|
G |
Prkar1b |
protein kinase cAMP-dependent type I regulatory subunit beta |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRKAR1B protein |
CTD |
PMID:34896426 |
|
NCBI chr12:15,492,233...15,624,942
Ensembl chr12:15,511,801...15,624,942
|
|
G |
Prl |
prolactin |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRL protein |
CTD |
PMID:34896426 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Prm1 |
protamine 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PRM1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRM1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PRM1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr10:4,871,817...4,872,312
|
|
G |
Prm2 |
protamine 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRM2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PRM2 mRNA |
CTD |
PMID:33396045 PMID:34896426 |
|
NCBI chr10:4,876,285...4,877,026
Ensembl chr10:4,873,372...4,877,026
|
|
G |
Psmd2 |
proteasome 26S subunit ubiquitin receptor, non-ATPase 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PSMD2 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:80,248,364...80,258,991
Ensembl chr11:80,248,364...80,259,043
|
|
G |
Ptdss2 |
phosphatidylserine synthase 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PTDSS2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:196,241,439...196,267,632
Ensembl chr 1:196,241,494...196,267,685
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of PTGS1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
EXP |
cyhalothrin results in increased expression of PTGS2 protein |
CTD |
PMID:37060950 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PTPRS protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:1,245,408...1,307,015
Ensembl chr 9:1,245,410...1,306,947
|
|
G |
Pygo2 |
pygopus family PHD finger 2 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PYGO2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PYGO2 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 2:174,849,670...174,854,758
Ensembl chr 2:174,849,936...174,854,758
|
|
G |
Rapgef2 |
Rap guanine nucleotide exchange factor 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RAPGEF2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:164,207,513...164,322,157
Ensembl chr 2:164,207,513...164,244,247
|
|
G |
Rbck1 |
RANBP2-type and C3HC4-type zinc finger containing 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of RBCK1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:140,789,079...140,806,017
Ensembl chr 3:140,789,080...140,806,005
|
|
G |
Recql |
RecQ like helicase |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RECQL protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases expression increases phosphorylation multiple interactions |
EXP |
cyhalothrin results in increased expression of RELA mRNA cyhalothrin results in increased phosphorylation of RELA protein thymoquinone inhibits the reaction [cyhalothrin results in increased expression of RELA mRNA] |
CTD |
PMID:26645134 PMID:37060950 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rexo5 |
RNA exonuclease 5 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of REXO5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:174,168,633...174,264,526
Ensembl chr 1:174,168,694...174,241,486
|
|
G |
Rimbp2 |
RIMS binding protein 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RIMBP2 protein |
CTD |
PMID:34896426 |
|
NCBI chr12:27,747,615...27,946,256
Ensembl chr12:27,747,980...27,956,763
|
|
G |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RIPOR2 protein |
CTD |
PMID:34896426 |
|
NCBI chr17:40,323,748...40,547,482
Ensembl chr17:40,323,867...40,548,092
|
|
G |
Rnf157 |
ring finger protein 157 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF157 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:101,571,972...101,639,874
Ensembl chr10:101,566,295...101,639,942
|
|
G |
Rnf2 |
ring finger protein 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF2 protein |
CTD |
PMID:34896426 |
|
NCBI chr13:63,553,964...63,584,047
Ensembl chr13:63,554,862...63,583,099
|
|
G |
Rnf8 |
ring finger protein 8 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF8 protein |
CTD |
PMID:34896426 |
|
NCBI chr20:7,682,258...7,710,448
Ensembl chr20:7,682,322...7,708,491
|
|
G |
Rora |
RAR-related orphan receptor A |
affects binding |
ISO |
cyhalothrin binds to RORA protein |
CTD |
PMID:32278787 |
|
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
|
|
G |
Rorc |
RAR-related orphan receptor C |
affects binding |
ISO |
cyhalothrin binds to RORC protein |
CTD |
PMID:32278787 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
G |
Rplp1 |
ribosomal protein lateral stalk subunit P1 |
increases expression |
EXP |
cyhalothrin results in increased expression of RPLP1 mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 8:62,394,008...62,395,341
Ensembl chr 8:62,393,177...62,395,339
|
|
G |
Rtel1 |
regulator of telomere elongation helicase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RTEL1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:168,427,247...168,465,349
Ensembl chr 3:168,419,579...168,465,348
|
|
G |
Sart1 |
spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SART1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:202,690,472...202,699,136
Ensembl chr 1:202,690,459...202,699,136
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
decreases expression multiple interactions |
EXP |
cyhalothrin results in decreased expression of SCARB1 mRNA; cyhalothrin results in decreased expression of SCARB1 protein [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of SCARB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SCARB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of SCARB1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of SCARB1 mRNA |
CTD |
PMID:30029170 PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Scg2 |
secretogranin II |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SCG2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:80,803,074...80,808,646
Ensembl chr 9:80,803,075...80,821,097
|
|
G |
Scn10a |
sodium voltage-gated channel alpha subunit 10 |
multiple interactions affects activity |
EXP |
cyhalothrin affects the reaction [SCN10A protein results in increased transport of Sodium] cyhalothrin affects the activity of SCN10A protein |
CTD |
PMID:16051293 PMID:19766671 |
|
NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
|
|
G |
Scn4b |
sodium voltage-gated channel beta subunit 4 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SCN4B protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:45,446,580...45,462,294
Ensembl chr 8:45,446,215...45,462,292
|
|
G |
Scnn1a |
sodium channel epithelial 1 subunit alpha |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SCNN1A protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:158,122,962...158,146,184
Ensembl chr 4:158,122,962...158,146,181
|
|
G |
Sec16b |
SEC16 homolog B, endoplasmic reticulum export factor |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SEC16B protein |
CTD |
PMID:34896426 |
|
NCBI chr13:69,665,757...69,727,199
Ensembl chr13:69,684,291...69,727,196
|
|
G |
Sema6c |
semaphorin 6C |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SEMA6C protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:182,733,635...182,750,066
Ensembl chr 2:182,737,474...182,746,856
|
|
G |
Sidt2 |
SID1 transmembrane family, member 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SIDT2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:46,232,379...46,248,913
Ensembl chr 8:46,232,383...46,248,700
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of SIRT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SIRT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of SIRT1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of SIRT1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc12a1 |
solute carrier family 12 member 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SLC12A1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:112,406,140...112,482,913
Ensembl chr 3:112,406,140...112,482,899
|
|
G |
Slc18a2 |
solute carrier family 18 member A2 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of SLC18A2 protein |
CTD |
PMID:28495607 |
|
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
|
|
G |
Slc26a3 |
solute carrier family 26 member 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC26A3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:48,023,892...48,064,829
Ensembl chr 6:48,023,892...48,064,772
|
|
G |
Slc38a5 |
solute carrier family 38, member 5 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC38A5 protein |
CTD |
PMID:34896426 |
|
NCBI chr X:14,213,727...14,222,498
Ensembl chr X:14,213,729...14,222,498
|
|
G |
Slc44a2 |
solute carrier family 44 member 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC44A2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:19,870,867...19,905,345
Ensembl chr 8:19,870,888...19,905,342
|
|
G |
Slc4a4 |
solute carrier family 4 member 4 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC4A4 protein |
CTD |
PMID:34896426 |
|
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
|
|
G |
Slc52a2 |
solute carrier family 52 member 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC52A2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:108,246,003...108,267,642
Ensembl chr 7:108,262,612...108,268,034
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
decreases expression increases expression |
EXP |
cyhalothrin results in decreased expression of SLC6A3 protein cyhalothrin results in increased expression of SLC6A3 mRNA |
CTD |
PMID:28495607 PMID:36126889 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of SLC6A4 mRNA |
CTD |
PMID:36126889 |
|
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
G |
Slc9a4 |
solute carrier family 9 member A4 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC9A4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:42,825,334...42,879,729
Ensembl chr 9:42,825,064...42,879,422
|
|
G |
Smarcad1 |
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1` |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SMARCAD1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:94,311,441...94,379,184
Ensembl chr 4:94,311,489...94,372,563
|
|
G |
Smc3 |
structural maintenance of chromosomes 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SMC3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:252,601,422...252,644,522
Ensembl chr 1:252,601,753...252,644,522
|
|
G |
Sned1 |
sushi, nidogen and EGF-like domains 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SNED1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:93,774,087...93,834,003
Ensembl chr 9:93,774,119...93,830,694
|
|
G |
Sobp |
sine oculis binding protein homolog |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SOBP protein |
CTD |
PMID:34896426 |
|
NCBI chr20:46,482,265...46,661,452
Ensembl chr20:46,482,765...46,663,541
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases activity |
EXP |
cyhalothrin results in increased activity of SOD2 protein |
CTD |
PMID:29727961 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of SOX9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SOX9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SOX9 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of SOX9 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
|
|
G |
Spag1 |
sperm associated antigen 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SPAG1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:67,361,474...67,421,369
Ensembl chr 7:67,361,477...67,421,368
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
affects binding |
ISO |
cyhalothrin binds to SRC protein |
CTD |
PMID:32278787 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
increases expression multiple interactions |
EXP ISO |
cyhalothrin results in increased expression of SREBF1 mRNA cyhalothrin results in increased expression of SREBF1 mRNA; cyhalothrin results in increased expression of SREBF1 protein [cyhalothrin co-treated with Oleic Acid] results in increased expression of SREBF1 protein; Metformin inhibits the reaction [[cyhalothrin co-treated with Oleic Acid] results in increased expression of SREBF1 protein] |
CTD |
PMID:27348886 PMID:36529352 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SREBF2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
|
|
G |
Ssrp1 |
structure specific recognition protein 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SSRP1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:70,124,371...70,134,481
Ensembl chr 3:70,118,655...70,134,482
|
|
G |
Stab2 |
stabilin 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of STAB2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:21,249,426...21,433,051
Ensembl chr 7:21,249,391...21,434,042
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions decreases expression |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of STAR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of STAR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of STAR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of STAR mRNA; Taurine inhibits the reaction [cyhalothrin results in decreased expression of STAR mRNA]; Taurine inhibits the reaction [cyhalothrin results in decreased expression of STAR protein] cyhalothrin results in decreased expression of STAR mRNA; cyhalothrin results in decreased expression of STAR protein |
CTD |
PMID:29506456 PMID:30029170 PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 More...
|
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
increases phosphorylation |
EXP |
cyhalothrin results in increased phosphorylation of STAT1 protein |
CTD |
PMID:37060950 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases phosphorylation |
EXP |
cyhalothrin results in increased phosphorylation of STAT3 protein |
CTD |
PMID:37060950 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stx12 |
syntaxin 12 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of STX12 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:145,062,978...145,092,423
Ensembl chr 5:145,063,587...145,092,377
|
|
G |
Syngap1 |
synaptic Ras GTPase activating protein 1 |
increases expression |
EXP |
cyhalothrin results in increased expression of SYNGAP1 protein |
CTD |
PMID:28487251 |
|
NCBI chr20:5,026,366...5,056,659
Ensembl chr20:5,026,364...5,056,672
|
|
G |
Synrg |
synergin, gamma |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SYNRG protein |
CTD |
PMID:34896426 |
|
NCBI chr10:68,848,828...68,931,252
Ensembl chr10:68,849,642...68,931,250
|
|
G |
Tab2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TAB2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:2,375,026...2,425,115
Ensembl chr 1:2,375,490...2,424,756
|
|
G |
Tbc1d2 |
TBC1 domain family, member 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBC1D2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:60,884,114...60,931,717
Ensembl chr 5:60,884,124...60,931,352
|
|
G |
Tbx5 |
T-box transcription factor 5 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBX5 protein |
CTD |
PMID:34896426 |
|
NCBI chr12:36,686,344...36,739,253
Ensembl chr12:36,688,014...36,734,885
|
|
G |
Tet1 |
tet methylcytosine dioxygenase 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TET1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TET1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TET1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr20:25,761,042...25,840,926
Ensembl chr20:25,768,120...25,833,052
|
|
G |
Tex14 |
testis expressed 14, intercellular bridge forming factor |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TEX14 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:72,231,766...72,356,938
Ensembl chr10:72,231,801...72,355,805
|
|
G |
Tff1 |
trefoil factor 1 |
increases expression |
ISO |
cyhalothrin results in increased expression of TFF1 mRNA |
CTD |
PMID:18419197 PMID:20097460 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TGFB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TGFB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TGFB1 protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TGFB1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
multiple interactions |
EXP |
[fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of TGFB2 mRNA |
CTD |
PMID:36053783 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgm1 |
transglutaminase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TGM1 protein |
CTD |
PMID:34896426 |
|
NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523
|
|
G |
Tgoln2 |
trans-golgi network protein 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TGOLN2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164
|
|
G |
Th |
tyrosine hydroxylase |
decreases expression |
EXP |
cyhalothrin results in decreased expression of TH mRNA; cyhalothrin results in decreased expression of TH protein |
CTD |
PMID:22366556 PMID:28495607 PMID:36126889 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
cyhalothrin inhibits the reaction [Triiodothyronine results in increased activity of THRB protein] |
CTD |
PMID:28531659 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of THY1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of THY1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
|
|
G |
Tigd5 |
tigger transposable element derived 5 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TIGD5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:107,596,724...107,599,243
Ensembl chr 7:107,596,724...107,599,243
|
|
G |
Tlr2 |
toll-like receptor 2 |
increases expression |
EXP |
cyhalothrin results in increased expression of TLR2 mRNA |
CTD |
PMID:37060950 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr4 |
toll-like receptor 4 |
increases expression |
EXP |
cyhalothrin results in increased expression of TLR4 mRNA |
CTD |
PMID:37060950 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP |
thymoquinone inhibits the reaction [cyhalothrin results in increased expression of TNF mRNA]; thymoquinone inhibits the reaction [cyhalothrin results in increased expression of TNF protein] cyhalothrin results in increased expression of TNF mRNA; cyhalothrin results in increased expression of TNF protein |
CTD |
PMID:26645134 PMID:27348886 PMID:28058584 PMID:37060950 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnp1 |
transition protein 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TNP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TNP1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 9:74,594,463...74,595,072
Ensembl chr 9:74,594,466...74,595,274
|
|
G |
Tnp2 |
transition protein 2 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of TNP2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TNP2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TNP2 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr10:4,879,812...4,880,540
Ensembl chr10:4,879,812...4,880,538
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO |
cyhalothrin results in increased expression of TRP53 mRNA |
CTD |
PMID:20097460 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tph2 |
tryptophan hydroxylase 2 |
decreases expression |
EXP |
cyhalothrin results in decreased expression of TPH2 mRNA |
CTD |
PMID:36126889 |
|
NCBI chr 7:50,685,694...50,789,424
Ensembl chr 7:50,685,694...50,789,424
|
|
G |
Trdmt1 |
tRNA aspartic acid methyltransferase 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TRDMT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRDMT1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT2 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr17:76,601,966...76,646,104
Ensembl chr17:76,610,543...76,645,439
|
|
G |
Trim35 |
tripartite motif-containing 35 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRIM35 protein |
CTD |
PMID:34896426 |
|
NCBI chr15:40,493,697...40,510,246
Ensembl chr15:40,493,755...40,510,240
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPA1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPC1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:96,263,322...96,314,220
Ensembl chr 8:96,263,329...96,314,276
|
|
G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPC3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:119,481,313...119,619,333
Ensembl chr 2:119,481,400...119,558,855
|
|
G |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPC4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:138,307,676...138,476,856
Ensembl chr 2:138,308,084...138,476,768
|
|
G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TRPM2 mRNA |
CTD |
PMID:33396045 PMID:34896426 |
|
NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
|
|
G |
Tsc22d3 |
TSC22 domain family, member 3 |
multiple interactions |
ISO |
cyhalothrin inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA] |
CTD |
PMID:26647222 |
|
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
|
|
G |
Tshb |
thyroid stimulating hormone subunit beta |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TSHB protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
|
|
G |
Tspo |
translocator protein |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of TSPO mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TSPO mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TSPO mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of TSPO mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
multiple interactions |
EXP |
cyhalothrin promotes the reaction [NGF protein results in increased expression of TUBB3 mRNA] |
CTD |
PMID:28385489 |
|
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
|
|
G |
Unc13b |
unc-13 homolog B |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of UNC13B protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:57,288,999...57,504,110
Ensembl chr 5:57,289,227...57,502,926
|
|
G |
Unc5d |
unc-5 netrin receptor D |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of UNC5D protein |
CTD |
PMID:34896426 |
|
NCBI chr16:62,860,119...63,406,932
Ensembl chr16:62,860,174...63,401,143
|
|
G |
Usp4 |
ubiquitin specific peptidase 4 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of USP4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:109,035,402...109,079,382
Ensembl chr 8:109,036,099...109,080,427
|
|
G |
Vav1 |
vav guanine nucleotide exchange factor 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of VAV1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:2,161,985...2,209,951
Ensembl chr 9:2,157,900...2,208,937
|
|
G |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of VEPH1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:150,291,379...150,537,491
Ensembl chr 2:150,296,573...150,537,266
|
|
G |
Vim |
vimentin |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of VIM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of VIM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of VIM mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Washc2c |
WASH complex subunit 2C |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WASHC2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:149,267,851...149,325,850
Ensembl chr 4:149,267,924...149,325,851
|
|
G |
Wdr26 |
WD repeat domain 26 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WDR26 protein |
CTD |
PMID:34896426 |
|
NCBI chr13:92,930,282...92,972,061
Ensembl chr13:92,930,285...92,977,295
|
|
G |
Wdr81 |
WD repeat domain 81 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WDR81 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:60,281,969...60,295,374
Ensembl chr10:60,281,972...60,295,296
|
|
G |
Wnt1 |
Wnt family member 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WNT1 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651
|
|
G |
Wnt4 |
Wnt family member 4 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of WNT4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of WNT4 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859
|
|
G |
Wt1 |
WT1 transcription factor |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WT1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of WT1 mRNA |
CTD |
PMID:34896426 PMID:36053783 |
|
NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643
|
|
G |
Xdh |
xanthine dehydrogenase |
decreases expression |
EXP |
cyhalothrin results in decreased expression of XDH mRNA |
CTD |
PMID:29727961 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
G |
Ybx2 |
Y box binding protein 2 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of YBX2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of YBX2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of YBX2 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr10:54,659,719...54,665,371
Ensembl chr10:54,659,719...54,665,371
|
|
G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of ZBTB16 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ZBTB16 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011
|
|
G |
Zfp148 |
zinc finger protein 148 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ZNF148 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:67,276,455...67,385,803
Ensembl chr11:67,281,707...67,385,772
|
|
G |
Zfp335 |
zinc finger protein 335 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ZNF335 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:153,618,587...153,648,213
Ensembl chr 3:153,627,467...153,647,054
|
|